# Diagnosis and management of mirror syndrome: a case series with emphasis on the potential role of the sFLT-1/PlGF ratio in clinical practice

**Authors:** Gabrielle Soares Behenck, Fernanda Curtois, Patrícia El Beitune, Mirela Foresti Jimenez, Janete Vettorazzi, Marcelo Brandão da Silva, Betania Muller, Lucas Teixeira, Carolina Longo, Gustavo Yano Callado, Edward Araujo Júnior, Talita Micheletti

PMC · DOI: 10.61622/rbgo/2026rbgo6 · 2026-02-20

## TL;DR

This study examines mirror syndrome in pregnant women, highlighting the potential use of the sFLT-1/PlGF ratio to help diagnose and manage the condition.

## Contribution

The study introduces the potential clinical utility of the sFLT-1/PlGF ratio in differentiating mirror syndrome from preeclampsia.

## Key findings

- Mirror syndrome often presents with maternal hypertension, proteinuria, and fetal hydrops.
- An elevated sFLT-1/PlGF ratio was associated with maternal complications or fetal death in most cases.
- Biomarker normalization after fetal loss allowed safe continuation of a twin pregnancy.

## Abstract

To characterize the maternal clinical, ultrasound, and laboratory parameters, maternal and perinatal outcomes of mirror syndrome, and to discuss the role of sFlt-1/PlGF biomarkers in diagnosis and management.

We conducted a case series including all cases of mirror syndrome diagnosed at a tertiary reference center in Brazil. Clinical, laboratory, ultrasound, and biomarker data were collected, along with maternal and perinatal outcomes.

Nine cases of mirror syndrome were identified, with a mean gestational age at diagnosis of 27+6 weeks. The most frequent maternal findings were lower limb edema (n=7), hypertension (n=8), and proteinuria (n=8). Ultrasound demonstrated fetal hydrops (n=7), polyhydramnios (n=6), and placentomegaly (n=7). Laboratory abnormalities included abnormal proteinuria/creatinuria ratio in 5/8 women tested, elevated 24-hour proteinuria in all 5, anemia in 7, thrombocytopenia in 3, and elevated creatinine in 1. The sFlt-1/PlGF ratio was measured in 5 women; 4 had abnormal results, with 3 above 85, all of whom developed maternal complications or fetal death. Resolution occurred after a mean of 3.4±3.6 days, due to fetal death (n=3), delivery (n=5), or fetal surgery (n=1). In one monochorionic twin pregnancy complicated by twin–anemia–polycythemia sequence, biomarker normalization after intrauterine death of the hydropic twin allowed safe prolongation of the pregnancy and term delivery of the co-twin.

Mirror syndrome should be suspected in pregnancies presenting with preeclampsia-like features in the setting of fetal hydrops or polyhydramnios. The sFlt-1/PlGF ratio may assist in differentiating mirror syndrome from preeclampsia and in identifying women at risk for adverse outcomes.

## Linked entities

- **Proteins:** Flt1 (FMS-like tyrosine kinase 1), PGF (placental growth factor)
- **Diseases:** preeclampsia (MONDO:0005081), twin–anemia–polycythemia sequence (MONDO:0019805)

## Full-text entities

- **Genes:** ENG (endoglin) [NCBI Gene 2022] {aka END, HHT1, ORW1}, PIGF (phosphatidylinositol glycan anchor biosynthesis class F) [NCBI Gene 5281] {aka OORS}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}, FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}
- **Diseases:** placental chorioangioma (MESH:D006391), pulmonary and renal dysfunction (MESH:C538458), fetal death (MESH:D005313), renal dysfunction (MESH:D007674), heart failure (MESH:D006333), sacrococcygeal teratoma (MESH:D013724), congenital heart disease (MESH:D006330), infection (MESH:D007239), aneurysm of the vein of Galen (MESH:C536535), thrombocytopenia (MESH:D013921), HELLP syndrome (MESH:D017359), placental (MESH:D010922), Mirror syndrome (OMIM:157600), deaths (MESH:D003643), hypertension (MESH:D006973), Anemia (MESH:D000740), ascites (MESH:D001201), Laboratory abnormalities (MESH:D007757), Polyhydramnios (MESH:D006831), lower (MESH:D017116), pericardial effusion (MESH:D010490), hypoxia (MESH:D000860), ischemia (MESH:D007511), proteinuria (MESH:D011507), polycythemia (MESH:D011086), fetal leukemia (MESH:D005315), Fetal hydrops (MESH:D015160), acute renal insufficiency (MESH:D058186), weight gain (MESH:D015430), pleural effusion (MESH:D010996), twin- (MESH:D004200), parvovirus B19 (MESH:D016731), cytomegalovirus (MESH:D003586), twin-twin transfusion syndrome (MESH:D005330), PE (MESH:D011225), transfusion syndrome (MESH:D065227), pulmonary edema (MESH:D011654), edema (MESH:D004487), renal failure (MESH:D051437), endothelial damage (MESH:D014652), Rh isoimmunization (MESH:C562717), nephrotic syndrome (MESH:D009404), fibrosis (MESH:D005355)
- **Chemicals:** creatinine (MESH:D003404), PTU (-), uric acid (MESH:D014527)
- **Species:** Human parvovirus B19 (no rank) [taxon 10798], Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975112/full.md

---
Source: https://tomesphere.com/paper/PMC12975112